• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Automated And Closed Cell Therapy Processing Systems Market is predicted to grow at a noteworthy speed to 2030 | TMR Research Study

Share:

December 13, 2021

The Automated And Closed Cell Therapy Processing Systems Market growth is on the back of the increasing popularity of regenerative medicines and cell therapies. In addition to this, various benefits that are provided by the automation technologies for the comprehensive development of therapies are also adding to the market growth.

The rising integration of advanced therapy development procedures and software technologies is also estimated to bring lucrative opportunities to the market. Further, bio manufacturers are investing at a high rate for the development of cellular therapy products with the help of series funding that is anticipated to drive growth impetus in the market in the years to come.

Rising partnerships among different market players for the adoption and application of these systems and increasing product count are also bolstering growth impetus in the market.

Automated And Closed Cell Therapy Processing Systems Market: Key Trends

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Recent years have encountered a massive growth in the clinical trials that are associated with advanced therapies. This market growth has been attributed to the rising demand for advanced and automated technologies. These technologies are used for the achievement of high throughput. This increased growth is possible with various benefits provided by these automated and closed systems. Reduced possibility of errors at the time of bioprocessing and better cell handling abilities are some of the most prominent benefits of these systems. Thus, owing to these factors, the automated and closed cell therapy processing systems market has been expected to grow at a noticeable speed in the forthcoming years.

There has been increased availability of a wide range of systems in the global market. These systems provide automated integrated workflow solutions along with partial automation. In addition to this, these systems also enable constant monitoring of the controlled therapy processing. These initiatives are helpful for the development of various novel therapeutics platforms. Thus, based on these factors, the automated and closed cell therapy processing systems market is experiencing various growth avenues.

Read more here

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Orexo Acquires Exclusive Us Rights to Commercialize Vorvida®, a Digital Therapy for Alcohol Use Disorder with Scientifically Proven EfficacyOrexo Acquires Exclusive Us Rights to Commercialize Vorvida®, a Digital Therapy for Alcohol Use Disorder with Scientifically Proven Efficacy
  • Health Insurance Innovations acquires direct-to-consumer platformHealth Insurance Innovations acquires direct-to-consumer platform
  • U.S. Telemedicine App Downloads Spikes During COVID-19 PandemicU.S. Telemedicine App Downloads Spikes During COVID-19 Pandemic
  • Consumer Awareness of Personalized Medicine Has Only Grown by 1% YoY Since 2013Consumer Awareness of Personalized Medicine Has Only Grown by 1% YoY Since 2013
  • PharmaDrug Completes Acquisition of Sairiyo Therapeutics Inc.PharmaDrug Completes Acquisition of Sairiyo Therapeutics Inc.
  • CBT Digital Therapeutic for IBS Patients Receives FDA De Novo Clearance (Updated)CBT Digital Therapeutic for IBS Patients Receives FDA De Novo Clearance (Updated)
  • OrigiMed Announced Its Strategic Partnership with Janssen to Develop Clinical Innovative Solutions Driven By Data ScienceOrigiMed Announced Its Strategic Partnership with Janssen to Develop Clinical Innovative Solutions Driven By Data Science
  • Eyeing Healthcare Providers, Microsoft Updates Its Team Coordination Platform with Interoperable EHR Support, Messaging FeaturesEyeing Healthcare Providers, Microsoft Updates Its Team Coordination Platform with Interoperable EHR Support, Messaging Features

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications